Reset filters
  • 21 September 2007

ICAAC: Phase 1 study provides `proof of concept` for PRO 140, a monoclonal CCR5 antibody

Read the article
  • 1 May 2007

Substantial HIV reduction persists for 2-3 weeks with single dose of PRO-140 antibody

Read the article
  • 30 September 2006

Antibody to CCR5 receptor safe, effective, suitable for weekly dosing, preliminary study shows

Read the article
  • 13 June 2003

Novel antibody enters trials as HIV treatment

Read the article

Receive the latest HIV research and conference news

Complete this form to receive regular email bulletins including the latest HIV research and conference news from aidsmap and/or updates from Terrence Higgins Trust.

Get regular email bulletins

Please let us know how you'd like to be contacted by ticking the options below.